share pullback present opportun var evolut emphas
high-growth high-margin offer upgrad buy pt
varian share pull back recent week
trade line comp group think deserv trade small
premium comp group compani grow revenu ep
faster peer enviabl market lead posit shift
busi toward faster grow higher margin area softwar single-us
devic believ uncertainti around china tariff radiat
oncolog altern payment model ro-apm pressur share
investor may brace paus hospit decis make temporari
order slowdown possibl near term upgrad call
quarter order model street think var sizeabl ou
busi could off-set previou note written like var
transform profil emphas softwar data high-margin offer
sinc long like var fundament view recent stock
pullback opportun upgrad upgrad buy set pt base
month ep estim multipl point group
acquisit late pull asset offer improv
data analyt better patient care via big data ai well cancer
acquisit may enabl compet effect emerg
bundl payment environ forward-think enabl
custom use data analyt patient-report outcom streamlin
treatment plan softwar treat effici set
high bar radiat oncolog player view would
surpris year var margin histor move
think investor reward stock move
retrench tariff reimburs chang think
minim manag impact see sell-off good time upgrad
acknowledg investor concern ro-apm may mean coupl
quarter order delay ahead expect long-term
phenomenon occur also note hospit may feel need
buy new system abl offer hypofraction treatment
major radiat oncolog player offer system may benefit
market leader cours capit equip world
especi time chang advantag well-known well-
capit compani overlook either
cancer elect concern circul media potenti
recess believ med-tech investor priorit invest compani
sell life-sav treatment radiat therapi clearli fit bill
addit evolv compani less reliant capit
equip sale approxim half total revenu make us less
worri potenti hospit capital-expenditure slowdown economi falter
though never saw slowdown even
valuat varian rate buy pt base
month non-gaap ep estim risk discuss
idc btig estim compani document
million except per share amount
varian world leader radiat therapi stereotact surgeri think offer superior technolog
faster treatment competitor rad onc market lumpi growth overal low mid-singl digit
demand halcyon product softwar offer value-ad servic drive higher growth rate
think trend continu increas order next year true spend drive
growth compani still grow ep faster peer believ deserv trade premium
above-market growth oncolog gross order revenu
stabl reimburs radiat oncolog
stabl economi capital-expenditure environ
continu abil off-set impact tariff
acceler oncolog gross order revenu growth
favor reimburs radiat oncolog
posit resolut trade war/tariff
improv economi capital-expenditure environ
varian world lead
manufactur radiat therapi
brachytherapi plan
market slowdown oncolog gross order revenu growth
neg develop reimburs radiat oncolog
slump economi capital-expenditure environ
updat model complet acquisit embol bead asset portfolio boston scientif
buy pt though acquisit financ cash borrow use assumpt compani
like pay back debt quickli
varian rate buy price target base month non-gaap ep estim varian trade
line comp group grow revenu ep faster rate risk includ halcyon adopt chang
oper margin capit spend slowdown hospit govern new competit healthcar multipl
gener trade lumpi quarterli result
comp tabl large-cap peer
gross incom ebit btig estim compani filingsnewold changecompanytickerr ptpricemarket cap bp/e ex-amortev/salescagrntm johnsonjnjnot pt bdxnot pt scientificbsxbuy factset data btig estimatespr
varian incom oncolog total y/i good gross sg one-tim total oper incom loss invest incom pre-tax incom incom non- net incom continu net earn discont op non-control non- dilut share net ex select calendar loss net product product product oper ep ep btig estim compani report
varian revenu eoncolog gross america y/i net america order y/i gross emea y/i net emea order y/i gross apac order y/i net apac y/i gross y/i net order y/i trail month gross trail month net y/i contract y/i oncolog y/i gross y/i y/i y/i gross y/i y/i y/i btig estim compani report
btig cover compani mention report
appendix analyst certif import disclosur
